CD4 and Splenomegaly: In Hashimoto’s article (42), patients with splenomegaly have a higher number of CD4+ regulatory T cells, PD-L1, and PD-L2 expression cells than those without splenomegaly, implying that patients with splenomegaly have poor tumor immunity.